Science Explorer Back to mapMap
Discussion
Researcher · Pfizer (United States) · United States

Robert E. Kyne

Robert E. Kyne publishes mostly in Organic Chemistry, Molecular Biology and Biotechnology, on topics such as Click Chemistry and Applications, Asymmetric Synthesis and Catalysis and Chemical Synthesis and Analysis.

OpenAlex
World rank
#2,123,237
of 7,710,434 ranked researchers
Rank in United States
#640,064
of 1,627,098
Works
31
Citations
1.3k
Citations per work
42.6
h-index
18
i10-index 20Top 27% in Organic Chemistry
Robert E. Kyne

What does Robert E. Kyne research?

Robert E. Kyne's work is mostly in Chemistry (61%), Biochemistry, Genetics and Molecular Biology (27%), Immunology and Microbiology (2%).

Physical Sciences: 19 works · 60.7% of their workChemistry: 19 works · 60.7% of their workOrganic Chemistry: 18 works · 57.3% of their workInorganic Chemistry: 1 works · 3.4% of their workLife Sciences: 9 works · 29.2% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 27.0% of their workMolecular Biology: 7 works · 22.5% of their workBiotechnology: 1 works · 4.5% of their workImmunology and Microbiology: 1 works · 2.2% of their workImmunology: 1 works · 2.2% of their workEverything else: 2 works · 7.9% of their workHealth Sciences: 1 works · 2.2% of their workMedicine: 1 works · 2.2% of their workGenetics: 1 works · 2.2% of their workTHEIR WORKRobert E. Kyne31works
Life Sciences29%Physical Sciences61%Health Sciences2%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Chemistry1960.7%
    1. Biochemistry, Genetics and Molecular Biology827.0%
    2. Immunology and Microbiology12.2%
  3. Everything else27.9%
    1. Medicine12.2%
  1. 1Organic Chemistry57% of their works
  2. 2Molecular Biology22% of their works
  3. 3Biotechnology4% of their works
  4. 4Inorganic Chemistry3% of their works
  5. 5Immunology2% of their works
  6. 6Genetics2% of their works

Research topics

Which keywords describe Robert E. Kyne's research?

The keywords of their largest research topics: Drug Discovery, Enantioselective Reactions, Transition Metal Complexes, Click Chemistry, Copper-Catalyzed Cycloaddition, Chiral Catalysts, Organocatalysis and Foldamers.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Drug Discovery142 topics
  2. Enantioselective Reactions102 topics
  3. Transition Metal Complexes92 topics
  4. Click Chemistry81 topic
  5. Copper-Catalyzed Cycloaddition81 topic
  6. Chiral Catalysts71 topic
  7. Organocatalysis71 topic
  8. Foldamers61 topic
  9. Frustrated Lewis Pairs61 topic
  10. Metal-Free Hydrogen Activation61 topic
  11. Peptide Synthesis61 topic
  12. Carbene Chemistry41 topic
  13. Cyclopropanation41 topic
  14. Glycosidase Inhibitors41 topic
  15. Marine Natural Products41 topic
  16. Oligosaccharide Synthesis41 topic
  17. Sponge-Associated Microorganisms41 topic
  18. Asymmetric Catalysis31 topic
  19. Hydrogenation31 topic

Where does Robert E. Kyne work?

Robert E. Kyne's main affiliation in the publication record is Pfizer (United States), United States.

How many publications and citations does Robert E. Kyne have?

OpenAlex counts 31 works and 1,321 citations for Robert E. Kyne, an h-index of 18, ranking #2,123,237 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Robert E. Kyne. Posts are plain text and can be reported.